<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10266">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00677690</url>
  </required_header>
  <id_info>
    <org_study_id>05/2008</org_study_id>
    <nct_id>NCT00677690</nct_id>
  </id_info>
  <brief_title>Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <official_title>Combination of Pulmonary Rehabilitation and Neuromuscular Electrical Stimulation and in COPD Patients: a Randomized Clinical Trial of Efficacy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Salvatore Maugeri</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione Salvatore Maugeri</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to elucidate whether combination of usual pulmonary
      rehabilitation and neuromuscular electrical stimulation of quadriceps may improve exercise
      capacity in patients affected by chronic obstructive pulmonary disease (COPD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neuromuscular electrical stimulation (NMES) has been extensively used as technique to
      improve muscle function in different areas of rehabilitation, however it seems to be more
      appropriate in critical care situation, while its use in more able patients is of uncertain
      benefit. In other words, NMES seems to be particularly effective in severely deconditioned
      and bed ridden patients. We therefore carried out a randomised trial to compare the efficacy
      of combination of NMES and PR (NM+PR) with combination of sham stimulation and PR (SS+PR) in
      a large population of moderately impaired COPD patients. Primary outcome was evaluation of
      effect of NMES on quadriceps strength and on exercise capacity. Secondary outcome was
      evaluation of effect of NMES on symptoms (dyspnoea) and quality of life.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Exercise Capacity</measure>
    <time_frame>5 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>6 minute walk test(6MWT)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quadriceps Strength</measure>
    <time_frame>5 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Quadriceps strength was assessed by means of Sit to Stand Test (STST). The subjects held their arms stationary by putting their hands on their hips. The subjects were asked to complete the sitting and standing positions without using the arms for support while rising and sitting. Once instructed, subjects stand upright and without delay sit down again, repeating the procedure as many times as possible in a 1 min period. The number of completed repetitions was recorded. The subjects were permitted to use rest periods to complete 1 min.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dyspnoea</measure>
    <time_frame>5 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The modified Medical Research Council (MMRC) scale was used for rating dyspnoea. MMRC is a five-point scale based on degrees of various physical activities that precipitate breathlessness. Scores on the MMRC dyspnoea scale can range from 0 (normal) to 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>5 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>St. George's respiratory questionnaire is a standardized self-administered airways disease-specific questionnaire divided into three subscales: symptoms (eight items), activity (16 items), and impacts (26 items). For each subscale and for the overall questionnaire, scores range from zero (no impairment) to 100 (maximum impairment).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Function</measure>
    <time_frame>5 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>forced expiratory volume in 1 second (FEV1)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">83</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>NM+PR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation (NM+PR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SS+PR</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients undergone to pulmonary rehabilitation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>neuromuscular electrical stimulation (NMES)</intervention_name>
    <description>NMES was applied by means of a commercially available four channel electrostimulator which generated a symmetrical biphasic pulsed current. Each session lasted 30 minutes and was performed 5 days/week for 5 weeks.</description>
    <arm_group_label>NM+PR</arm_group_label>
    <other_name>pulmonary rehabilitation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham electrical stimulation</intervention_name>
    <description>Sham stimulation was performed with the same modality and time, but the stimulus was set up at 5 Hz.</description>
    <arm_group_label>SS+PR</arm_group_label>
    <other_name>pulmonary rehabilitation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of COPD

          -  Must be able to walk

        Exclusion Criteria:

          -  Previous or current diagnosis of chronic respiratory failure

          -  A history of diseases other than COPD, in particular neurological disease

          -  Need for treatment with systemic steroids during the rehabilitation period
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ercole zanotti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione Maugeri</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri</name>
      <address>
        <city>Montescano</city>
        <state>Pavia</state>
        <zip>27040</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <lastchanged_date>November 4, 2011</lastchanged_date>
  <firstreceived_date>May 8, 2008</firstreceived_date>
  <firstreceived_results_date>January 5, 2009</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione Salvatore Maugeri</investigator_affiliation>
    <investigator_full_name>Ercole Zanotti</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>2007-2008 - Rehabilitative Pulmonary ward</recruitment_details>
      <pre_assignment_details>167 COPD patients were admitted.52 out of 167 did not meet the inclusion criteria.19 out of the remaining 115 patients refused to participate.13 out of 96 subjects subsequently dropped out due to acute exacerbation.Our definitive sample was therefore of 83 subjects</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Neuromuscular Stimulation and Pulmonary Rehabilitation</title>
          <description>Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation</description>
        </group>
        <group group_id="P2">
          <title>Pulmonary Rehabilitation</title>
          <description>Patients undergone to pulmonary rehabilitation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Neuromuscular Stimulation and Pulmonary Rehabilitation</title>
          <description>Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation</description>
        </group>
        <group group_id="B2">
          <title>Pulmonary Rehabilitation</title>
          <description>Patients undergone to pulmonary rehabilitation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="42"/>
                <measurement group_id="B2" value="41"/>
                <measurement group_id="B3" value="83"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="11"/>
                <measurement group_id="B2" value="9"/>
                <measurement group_id="B3" value="20"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="31"/>
                <measurement group_id="B2" value="32"/>
                <measurement group_id="B3" value="63"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="61.4" spread="7.6"/>
                <measurement group_id="B2" value="62.8" spread="5.4"/>
                <measurement group_id="B3" value="62.1" spread="8.4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="11"/>
                <measurement group_id="B2" value="12"/>
                <measurement group_id="B3" value="23"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="31"/>
                <measurement group_id="B2" value="29"/>
                <measurement group_id="B3" value="60"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Italy</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="42"/>
                <measurement group_id="B2" value="41"/>
                <measurement group_id="B3" value="83"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Dyspnoea</title>
        <description>The modified Medical Research Council (MMRC) scale was used for rating dyspnoea. MMRC is a five-point scale based on degrees of various physical activities that precipitate breathlessness. Scores on the MMRC dyspnoea scale can range from 0 (normal) to 4.</description>
        <time_frame>5 weeks</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Neuromuscular Stimulation and Pulmonary Rehabilitation</title>
            <description>Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation</description>
          </group>
          <group group_id="O2">
            <title>Pulmonary Rehabilitation</title>
            <description>Patients undergone to pulmonary rehabilitation</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="42"/>
                  <measurement group_id="O2" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Dyspnoea</title>
            <description>The modified Medical Research Council (MMRC) scale was used for rating dyspnoea. MMRC is a five-point scale based on degrees of various physical activities that precipitate breathlessness. Scores on the MMRC dyspnoea scale can range from 0 (normal) to 4.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="0.4"/>
                  <measurement group_id="O2" value="2.6" spread="0.2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>All data were expressed as the mean ± SD. The level of significance for all tests was set at p &lt; 0.05.
Inter- and intra-group comparisons were performed using both paired and unpaired t tests for continuous variables and Chi squared for categorical variables.</groups_desc>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt; 0.05</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Exercise Capacity</title>
        <description>6 minute walk test(6MWT)</description>
        <time_frame>5 weeks</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Neuromuscular Stimulation and Pulmonary Rehabilitation</title>
            <description>Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation</description>
          </group>
          <group group_id="O2">
            <title>Pulmonary Rehabilitation</title>
            <description>Patients undergone to pulmonary rehabilitation</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="42"/>
                  <measurement group_id="O2" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Exercise Capacity</title>
            <description>6 minute walk test(6MWT)</description>
            <units>meters</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="465.5" spread="101.7"/>
                  <measurement group_id="O2" value="462.7" spread="96.9"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life</title>
        <description>St. George's respiratory questionnaire is a standardized self-administered airways disease-specific questionnaire divided into three subscales: symptoms (eight items), activity (16 items), and impacts (26 items). For each subscale and for the overall questionnaire, scores range from zero (no impairment) to 100 (maximum impairment).</description>
        <time_frame>5 weeks</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Neuromuscular Stimulation and Pulmonary Rehabilitation</title>
            <description>Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation</description>
          </group>
          <group group_id="O2">
            <title>Pulmonary Rehabilitation</title>
            <description>Patients undergone to pulmonary rehabilitation</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="42"/>
                  <measurement group_id="O2" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Quality of Life</title>
            <description>St. George's respiratory questionnaire is a standardized self-administered airways disease-specific questionnaire divided into three subscales: symptoms (eight items), activity (16 items), and impacts (26 items). For each subscale and for the overall questionnaire, scores range from zero (no impairment) to 100 (maximum impairment).</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="41.7" spread="14.8"/>
                  <measurement group_id="O2" value="42.05" spread="15.7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Quadriceps Strength</title>
        <description>Quadriceps strength was assessed by means of Sit to Stand Test (STST). The subjects held their arms stationary by putting their hands on their hips. The subjects were asked to complete the sitting and standing positions without using the arms for support while rising and sitting. Once instructed, subjects stand upright and without delay sit down again, repeating the procedure as many times as possible in a 1 min period. The number of completed repetitions was recorded. The subjects were permitted to use rest periods to complete 1 min.</description>
        <time_frame>5 weeks</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Neuromuscular Stimulation and Pulmonary Rehabilitation</title>
            <description>Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation</description>
          </group>
          <group group_id="O2">
            <title>Pulmonary Rehabilitation</title>
            <description>Patients undergone to pulmonary rehabilitation</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="42"/>
                  <measurement group_id="O2" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Quadriceps Strength</title>
            <description>Quadriceps strength was assessed by means of Sit to Stand Test (STST). The subjects held their arms stationary by putting their hands on their hips. The subjects were asked to complete the sitting and standing positions without using the arms for support while rising and sitting. Once instructed, subjects stand upright and without delay sit down again, repeating the procedure as many times as possible in a 1 min period. The number of completed repetitions was recorded. The subjects were permitted to use rest periods to complete 1 min.</description>
            <units>repetitions</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="13.5" spread="0.83"/>
                  <measurement group_id="O2" value="13.6" spread="0.99"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Function</title>
        <description>forced expiratory volume in 1 second (FEV1)</description>
        <time_frame>5 weeks</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Neuromuscular Stimulation and Pulmonary Rehabilitation</title>
            <description>Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation</description>
          </group>
          <group group_id="O2">
            <title>Pulmonary Rehabilitation</title>
            <description>Patients undergone to pulmonary rehabilitation</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="42"/>
                  <measurement group_id="O2" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Respiratory Function</title>
            <description>forced expiratory volume in 1 second (FEV1)</description>
            <units>percentage of predicted value</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="50.1" spread="6.4"/>
                  <measurement group_id="O2" value="49.6" spread="8.2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Neuromuscular Stimulation and Pulmonary Rehabilitation</title>
          <description>Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation</description>
        </group>
        <group group_id="E2">
          <title>Pulmonary Rehabilitation</title>
          <description>Patients undergone to pulmonary rehabilitation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ercole Zanotti</name_or_title>
      <organization>Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy</organization>
      <phone>39 385 247 ext 324</phone>
      <email>ercole.zanotti@fsm.it</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
